| Gene Symbol | G007 |
| Full Name | LK: LRRK2 Kinase Inhibitor |
| GeneCards | G007 |
| Human Protein Atlas | G007 |
| Parameter | Value |
| Oral bioavailability | >60% (rat), >50% (dog) |
| Brain-to-plasma ratio | 1.2-1.5 |
| Half-life (rodent) | 4-6 hours |
| Once-daily dosing | Suitable |
| CYP inhibition | Low (favorable drug-drug interaction profile) |
| Development Stage | Preclinical / IND-enabling |
| Company | Vanqua Bio (collaboration with Genentech/Roche) |
| Indication | Parkinson's disease (LRRK2 mutation carriers) |
| Route | Oral (small molecule) |
| Dosing | Once-daily |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |